Call for Papers

Go straight to online submission form

Abstract submission deadline: December 15, 2006

Contributions are invited for oral and poster presentation at the conference. Please submit abstracts for both oral and poster presentations using the Online Submission Form by December 15, 2006.

All abstracts will be refereed and a criterion of rejection will be lack of originality. A condition of submission is that, if accepted, the paper will be presented at the First World Congress of the IAOO by one of the authors. Accepted abstracts will be published in Oral Oncology Supplement (1744-7895) which is published by Elsevier Ltd in print and online on ScienceDirect.  Each delegate will receive a copy of Oral Oncology Supplement at the conference.

Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence. Allow at least 2 hours for your receipt to be returned to you.

For revisions or queries regarding abstracts already submitted
If you do not receive acknowledgement for your abstract submission or you wish to make any essential revisions to an abstract already submitted, please DO NOT RESUBMIT your abstract, as this may lead to duplication. Please email the Conference Secretariat with details of any revisions or queries. Please quote your reference number if you have one.

Points of note for authors submitting abstracts:

Ethics: For clinical trials, details of ethical committee approval and the type of informed consent should be stated. Patients' and volunteers' names, initials, and hospital numbers should not be used.

Conflict of Interest: All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. This information should be included in a separate section with a sub-heading, "Conflict of Interest Statement".

Role of the Funding Source: All sources of funding should be declared as an acknowledgment at the end of the text.

Awards

Awards will be presented to the authors of the best clinical and best science based papers.

Conflict of Interest and Quality Assurance

The information presented at the 1st World Congress of the International Academy of Oral Oncology (IAOO) and the sponsored CME Activities will be unbiased and based on scientific evidence.  To help participants make judgments about the presence of bias, the Congress will provide information that speakers have disclosed about financial relationships they have with commercial entities, that produce or market products or services related to the content of CME Activities.  The disclosure information will be made available in the 1st World Congress of the IAOO, distributed in advance of the meeting and on site.  In addition, presenters and faculty members and the presence of such relationship will be reported to the program attendees, both in the program’s printed material and at the presentation.  In addition, presenters and faculty members shall disclose their intent to discuss drugs or devices or the uses of drugs or devices that have not been approved by the Food and Drug Administration (FDA) of USA and the equivalent authority of the European Union (EU). Reasonable efforts will be taken intending for educational subject matters to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions.

The 1st World Congress of the IAOO is committed to the non promotional advancement of knowledge and science in the research and treatment of oral cancer.